Clinical Trials Directory

Trials / Completed

CompletedNCT01889823

Effects of Oxygen Status on Hypoxia Inducible Factor 1-α and Inflammation. A Pilot Proof of Principle Study.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

It has been shown in in vitro and animal models that hypoxia can have pro-inflammatory effects and hyperoxia can have anti-inflammatory effects. The pro-inflammatory effect could be the result of activation of Hypoxia Inducible Factor, a transcription factor that is known to activate many cell systems aimed at cell survival, including the inflammatory response. The anti-inflammatory effects of hyperoxia could be the annihilation of Hypoxia Inducible Factor, but also a decrease in inflammation due to oxygen toxicity resulting in a decrease in clearance of pathogens. These effects have been sparsely studied in humans. Therefore, we hypothesize that hypoxia results in an increase in Hypoxia Inducible Factor in circulating leukocytes and increases inflammatory reactions, whereas hyperoxia decreases these reactions.

Conditions

Interventions

TypeNameDescription
OTHERHypoxiaSubjects will be breathing an individualized mix of nitrogen and room air titrated to an oxygen saturation of 80-85%.
OTHERHyperoxiaSubjects will be breathing 100% oxygen

Timeline

Start date
2013-06-01
Primary completion
2013-08-01
Completion
2014-12-01
First posted
2013-06-28
Last updated
2015-03-25

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01889823. Inclusion in this directory is not an endorsement.